Michael St. Andre is currently a Principal Scientist at Entrada Therapeutics, specializing in pharmacology and preclinical drug development. They previously held roles as a Senior Scientist and Scientist at Pfizer from 2019 to 2021. Michael earned a Doctor of Philosophy in Biomolecular Pharmacology from Boston University School of Medicine, completing their degree in 2021.
This person is not in the org chart
This person is not in any teams
This person is not in any offices